Search research articles
Contact Us
Filters
Showing results (31-40 of 213) with videos related to
Page
of 22
Sort By:
ESC Heart Failure
|
February 5, 2021
Meta-analysis of the effects of four factors on the efficacy of SGLT2 inhibitors in patients with HFrEF
Mei Qiu, Liang-Liang Ding, Ze-Lin Zhan, et al.
Frontiers in Microbiology
|
September 30, 2016
Transcription Profiling Analysis of Mango-Fusarium mangiferae Interaction
Feng Liu, Jing-Bo Wu, Ru-Lin Zhan, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica
|
March 16, 2016
[Cloning and functional characterization of phytoene desaturase in Andrographis paniculata]
Qin-qin Shen, Li-xia Li, Peng-lin Zhan, et al.
European Journal of Internal Medicine
|
January 24, 2021
Do four SGLT2 inhibitors lead to different cardiorenal benefits in type 2 diabetes, in chronic heart failure, and in chronic kidney disease?
Mei Qiu, Liang-Liang Ding, Ze-Lin Zhan, et al.
Research in Gerontological Nursing
|
January 19, 2010
Dehydration reduction in community-dwelling older adults: perspectives of community health care providers
Lisa Abdallah, Ruth Remington, Susan Houde, et al.
Cardiovascular Drugs and Therapy
|
June 28, 2021
Sotagliflozin Reduces HF Events in T2DM Regardless of Baseline Characteristics, Including HF, CKD and LVEF
Li-Min Zhao, Liang-Liang Ding, Ze-Lin Zhan, et al.
Current Oncology (Toronto, Ont.)
|
January 27, 2021
Real-World Palbociclib Use in HR+/HER2- Advanced Breast Cancer in Canada: The IRIS Study
Katie Mycock, Lin Zhan, Gavin Taylor-Stokes, et al.
Heart Failure Reviews
|
May 4, 2021
Letter to the Editor regarding the article "SGLT2 inhibitors and cardiovascular and renal outcomes: a meta‑analysis and trial sequential analysis"
Mei Qiu, Liang-Liang Ding, Ze-Lin Zhan, et al.
European Journal of Internal Medicine
|
March 16, 2021
SGLT2 inhibitors should be recommended in patients with one or more of the three diseases: type 2 diabetes, chronic kidney disease, and HFrEF
Li-Min Zhao, Liang-Liang Ding, Ze-Lin Zhan, et al.
ANS. Advances in Nursing Science
|
October 31, 2012
The influence of social environmental factors on rehospitalization among patients receiving home health care services
Hong Tao, Carol Hall Ellenbecker, Jie Chen, et al.
Page
of 22
Search research articles
Search
Showing results (31-40 of 213) with videos related to
Sort By:
Page
of 22
ESC Heart Failure
|
February 5, 2021
Meta-analysis of the effects of four factors on the efficacy of SGLT2 inhibitors in patients with HFrEF
Mei Qiu, Liang-Liang Ding, Ze-Lin Zhan, et al.
Frontiers in Microbiology
|
September 30, 2016
Transcription Profiling Analysis of Mango-Fusarium mangiferae Interaction
Feng Liu, Jing-Bo Wu, Ru-Lin Zhan, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica
|
March 16, 2016
[Cloning and functional characterization of phytoene desaturase in Andrographis paniculata]
Qin-qin Shen, Li-xia Li, Peng-lin Zhan, et al.
European Journal of Internal Medicine
|
January 24, 2021
Do four SGLT2 inhibitors lead to different cardiorenal benefits in type 2 diabetes, in chronic heart failure, and in chronic kidney disease?
Mei Qiu, Liang-Liang Ding, Ze-Lin Zhan, et al.
Research in Gerontological Nursing
|
January 19, 2010
Dehydration reduction in community-dwelling older adults: perspectives of community health care providers
Lisa Abdallah, Ruth Remington, Susan Houde, et al.
Cardiovascular Drugs and Therapy
|
June 28, 2021
Sotagliflozin Reduces HF Events in T2DM Regardless of Baseline Characteristics, Including HF, CKD and LVEF
Li-Min Zhao, Liang-Liang Ding, Ze-Lin Zhan, et al.
Current Oncology (Toronto, Ont.)
|
January 27, 2021
Real-World Palbociclib Use in HR+/HER2- Advanced Breast Cancer in Canada: The IRIS Study
Katie Mycock, Lin Zhan, Gavin Taylor-Stokes, et al.
Heart Failure Reviews
|
May 4, 2021
Letter to the Editor regarding the article "SGLT2 inhibitors and cardiovascular and renal outcomes: a meta‑analysis and trial sequential analysis"
Mei Qiu, Liang-Liang Ding, Ze-Lin Zhan, et al.
European Journal of Internal Medicine
|
March 16, 2021
SGLT2 inhibitors should be recommended in patients with one or more of the three diseases: type 2 diabetes, chronic kidney disease, and HFrEF
Li-Min Zhao, Liang-Liang Ding, Ze-Lin Zhan, et al.
ANS. Advances in Nursing Science
|
October 31, 2012
The influence of social environmental factors on rehospitalization among patients receiving home health care services
Hong Tao, Carol Hall Ellenbecker, Jie Chen, et al.
Page
of 22